Literature DB >> 30005936

Exceptional Response to Cabozantinib of Rapidly Evolving Brain Metastases of Renal Cell Carcinoma: A Case Report and Review of the Literature.

Chiara Ciccarese1, Roberto Iacovelli2, Claudia Mosillo2, Giampaolo Tortora2.   

Abstract

Entities:  

Keywords:  Antiangiogenic targeted agents; Blood–brain barrier penetration; Brain metastases; Complete response; RCC

Mesh：

Substances：

Year:  2018        PMID： 30005936     DOI： 10.1016/j.clgc.2018.06.005

Source DB:  PubMed          Journal:  Clin Genitourin Cancer        ISSN： 1558-7673            Impact factor:   2.872


× No keyword cloud information.
  6 in total

1.  No paradigm changes with checkpoint inhibitor monotherapy in patients with metastatic renal cell carcinoma and brain metastases.

Authors:  Sergio Bracarda; Claudia Mosillo; Fabio Trippa; Federica Urbano; Ernesto Maranzano; Claudia Caserta
Journal:  Ann Transl Med       Date:  2019-11

2.  Efficacy of cabozantinib therapy for brain metastases from renal cell carcinoma.

Authors:  Takashi Nakagawa; Toshiki Kijima; Naoki Imasato; Akihiko Nagoshi; Gaku Nakamura; Toshitaka Uematsu; Issei Suzuki; Daisaku Nishihara; Takao Kamai
Journal:  IJU Case Rep       Date:  2022-05-03

3.  TRK xDFG Mutations Trigger a Sensitivity Switch from Type I to II Kinase Inhibitors.

Authors:  Ji Eun Lee; Srinivasaraghavan Kannan; Alison M Schram; Emiliano Cocco; Helen H Won; Sophie Shifman; Amanda Kulick; Laura Baldino; Eneda Toska; Amaia Arruabarrena-Aristorena; Srushti Kittane; Fan Wu; Yanyan Cai; Sabrina Arena; Benedetta Mussolin; Ram Kannan; Neil Vasan; Alexander N Gorelick; Michael F Berger; Ofra Novoplansky; Sankar Jagadeeshan; Yi Liao; Uwe Rix; Sandra Misale; Barry S Taylor; Alberto Bardelli; Jaclyn F Hechtman; David M Hyman; Moshe Elkabets; Elisa de Stanchina; Chandra S Verma; Andrea Ventura; Alexander Drilon; Maurizio Scaltriti
Journal:  Cancer Discov       Date:  2020-10-01       Impact factor: 39.397

4.  Activity of cabozantinib in radioresistant brain metastases from renal cell carcinoma: two case reports.

Authors:  Sylvie Négrier; Guillaume Moriceau; Valéry Attignon; Véronique Haddad; Daniel Pissaloux; Nicole Guerin; Christian Carrie
Journal:  J Med Case Rep       Date:  2018-11-25

Review 5.  Cabozantinib for the Management of Metastatic Clear Cell Renal Cell Carcinoma.

Authors:  Sharon J Del Vecchio; Robert J Ellis
Journal:  J Kidney Cancer VHL       Date:  2018-10-08

Review 6.  RET signaling pathway and RET inhibitors in human cancer.

Authors:  Angelina T Regua; Mariana Najjar; Hui-Wen Lo
Journal:  Front Oncol       Date:  2022-07-25       Impact factor: 5.738
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.